ABSTRACr Lung uptake and excretion of n-hexane were studied in ten workers in a shoe factory. Simultaneous samples of inhaled and alveolar air were collected with the aid of a Rhan-Otis valve, personal samplers, and charcoal tubes. Alveolar excretion was monitored during a six hour postexposure period. Uptake was calculated from lung ventilation, the retention coefficient, and environmental concentrations. The amount of exhaled n-hexane was calculated from the decay curve. According to the experimental data, alveolar retention was about 25% of the inhaled n-hexane, corresponding to a lung uptake of about 17%. The postexposure alveolar excretion was about 10% of the total uptake. The main metabolites of n-hexane were identified and measured by capillary GC/MS in spot urine samples collected before, at the end, and 15 hours after the same working shift. Urinary concentrations were low, though related to n-hexane in the air. 2,5-Hexanedione in the end of shift samples gave the best estimate of overall exposure. About 3 mg/g creatinine of 2,5-hexanedione would correspond to about 50 ppm of n-hexane in the air (mean daily exposure).
The use of n-hexane is widespread in industry. It is an excellent and inexpensive solvent used especially in glues, varnishes, and paints. Many mixtures are commercially available, and the most common among them contain different proportions of n-hexane and its isomers 2-methyl and 3-methyl pentane, cyclohexane, and methyl ethyl ketone. Occupational exposures have been reported to cause peripheral neuropathies in workers'-3; electrophysiological changes have also been found in subjects exposed to relatively low airborne concentrations. 48 The pharmacokinetics of n-hexane has been widely investigated in rats but much less is known for man. Among the published studies there is little agreement about the retention of inhaled n-hexane and about the proportion which is excreted through the lung during the postexposure period. the metabolism of n-hexane in man, with the aim of evaluating more specifically: (a) the respiratory uptake and elimination in workers occupationally exposed under constant model ventilation conditions; (b) the possible relation between n-hexane uptake and urinary excretion of its metabolites; and (c) the usefulness of either alveolar concentration or urinary excretion of n-hexane metabolites for biological monitoring purposes.
Method
The study was performed on 10 young healthy , and the flow rate 1 ml helium per minute. Particular interest was focused on the following metabolites: 2 and 3-hexanol, 2,5-hexanediol, methyl n-butyl ketone, 2,5 hexanedione, y-valerolactone, and 2,5-dimethylfuran. Authentic samples of each substance were obtained from Fluka AG (Buchs, Switzerland). The urinary metabolites were identified on the basis of gas chromatographic retention time, and their mass spectra were compared with those of authentic samples, using a Finnigan MAT 1020 mass spectrometer (Finnigan MAT, Cincinnati, OH, USA).
EQUATIONS
Intake, uptake, and alveolar excretion were calculated according to the following equations:
where Ca = alveolar concentration of n-hexane (ppm); C = inhaled concentration of n-hexane (ppm); (A) = time weighted average of breathing zone levels of n-hexane (ppm); R = pulmonary retention coefficient; Ve = respiratory minute volume (1/min); Va = alveolar ventilation, calculated according to Astrand" (1/min); t = time (min); I = total respiratory intake (mg); D = alveolar uptake or dose (mg); E = alveolar excretion (mg); and k = factor converting ppm to mg/l (3.5 x 10-3).
Results
Technical grade hexane is a mixture containing variable proportions of n-hexane, of its isomers, and of group.bmj.com on July 6, 2017 -Published by http://oem.bmj.com/ Downloaded from n-Hexane metabolism in occupationally exposed workers other solvents. The main components of the mixture used by our study subjects and their 8 h time weighted average (TWA) concentrations in the air during the study are summarised in table 1. The solvent concentrations showed a wide scatter, the exposure to n-hexane ranging from a few to more than 1000 mg/iM3. Figure 2 shows the time course of n-hexane intake and uptake during exposure in a study subject and that of alveolar excretion during the postexposure period. From the difference between alveolar uptake and excretion it seems reasonable to conclude that a considerable amount of absorbed n-hexane was either retained or metabolised. In summarised in table 2. The difference in the inhaled and alveolar concentrations indicates that about 25% of alveolar n-hexane is taken up by the blood. Absorption in relation to the total respiratory intake is only 17%, taking into account both the retention coefficient and alveolar ventilation. It should be emphasised that the physical load while working was group.bmj.com on July 6, 2017 -Published by http://oem.bmj.com/ Downloaded from n-Hexane metabolism in occupationally exposed workers median uptake was 166 mg during the whole working shift.
The main urinary metabolite appeared to be 2,5-hexanedione, particularly in the end of shift sample. A good relation was found between exposure to n-hexane, as measured by its TWA concentration in the air, and the urinary excretion of 2,5-hexanedione at the end of the working day (fig 4) . Nevertheless the scattergram suggests that the measurement of 2,5-hexanedione in the urine is not sensitive enough to detect exposures below 50 mg/ mi3. Figure 5 shows a typical chromatogram of one end of shift urine spot sample. It can be seen that the identification of each metabolite and the interpretation of analytical results is a difficult task.
Discussion
A direct comparison with other field and experimental studies is not possible because of the differences in the methods used. There is, however, a reasonable agreement among the alveolar retention coefficients reported by Brugnone et al,2 by Veulemans et al,3 and that found in the present study. In contrast to the retention data ranging from 0*164 to 02522 reported above a value of 0056 was found by Nomiyama et al. '4 In agreement with the experimental study of Veulemans et al, '3 we found that the postexposure alveolar excretion was biphasic and the half lives were similar to those of Veulemans despite the different exposure levels. According to the same authors, the short half life of the fast phase would cause a high variability in the measurements of the concentration of n-hexane in breath samples taken at specified time intervals. As a result, the alveolar concentration does not give better information about the absorbed dose during the whole exposure period than the measurement of the environmental concentration. As shown earlier by 
